Ocular Therapeutix, Inc. (FRA:0OT)

Germany · Delayed Price · Currency is EUR

10.41

+0.07 (0.68%)

At close: Nov 28, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Bioresorbable Hydrogel-based Formulation Technology	63.46M	Log In	Log In	Log In	Log In	Upgrade
Bioresorbable Hydrogel-based Formulation Technology Growth	9.66%	Log In	Log In	Log In	Log In	Upgrade
Collaboration	262.00K	Log In	Log In	Log In	Log In	Upgrade
Collaboration Growth	-54.28%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	63.72M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	9.03%	Log In	Log In	Log In	Log In	Upgrade